Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Telix Pharmaceuticals Ltd. has updated its Securities Dealing Policy as of December 2024, aligning with ASX Listing Rule 12.10. This biopharmaceutical company, known for its focus on innovative radiopharmaceuticals, continues to capture attention in the financial markets with its international operations and promising oncology products.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
